{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
M K Proteins Ltd
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
M K Proteins Ltd Falls 4.51%: 2 Key Events Shaping This Week’s Volatility
M K Proteins Ltd experienced a turbulent week ending 6 March 2026, with its share price declining 4.51% from Rs.5.10 to Rs.4.87, slightly underperforming the Sensex’s 3.00% fall over the same period. The stock’s volatility was marked by a fresh 52-week low and an unusual upper circuit event on 4 March, reflecting mixed investor sentiment amid sectoral headwinds and broader market weakness.
M K Proteins Ltd Stock Falls to 52-Week Low of Rs.4.45
M K Proteins Ltd, a player in the edible oil sector, recorded a new 52-week low of Rs.4.45 today, marking a significant decline in its stock price amid broader market pressures and sectoral headwinds.
M K Proteins Ltd Hits Upper Circuit Amid Strong Buying Pressure Despite Recent Downtrend
M K Proteins Ltd, a micro-cap player in the edible oil sector, witnessed a remarkable trading session on 4 Mar 2026 as it hit its upper circuit price limit, reflecting intense buying interest despite recent bearish trends. The stock’s surge comes amid a backdrop of sectoral weakness and regulatory trading freezes, underscoring a complex market dynamic for investors.
Why is M K Proteins Ltd falling/rising?
As of 02-Mar, M K Proteins Ltd’s stock price has fallen by 3.33% to ₹4.93, reflecting ongoing challenges in both its financial performance and market positioning relative to benchmarks and sector peers.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 February 2026, providing investors with the latest insights into its performance and outlook.
When is the next results date for M K Proteins Ltd?
The next results date for M K Proteins Ltd is 13 February 2026.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
M K Proteins Ltd is Rated Sell
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with the latest insights into its performance and outlook.
M K Proteins Ltd Stock Falls to 52-Week Low of Rs.5.11
M K Proteins Ltd, a player in the edible oil sector, recorded a fresh 52-week low of Rs.5.11 today, marking a significant decline in its stock price amid a broader market downturn and persistent underperformance relative to its sector and benchmark indices.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date view of the company's performance and outlook.
M K Proteins Sees Revision in Market Evaluation Amid Mixed Financial Signals
M K Proteins, a microcap player in the edible oil sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid ongoing challenges in the company’s financial performance and stock price trends, underscoring the complexities faced by investors in this segment.
How has been the historical performance of M K Proteins?
M K Proteins' historical performance shows fluctuating revenue, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability decreased, with operating profit falling to 12.43 Cr and cash flow showing a negative trend, indicating challenges in profitability and cash management despite some sales growth.
Is M K Proteins overvalued or undervalued?
As of November 19, 2025, M K Proteins is considered very attractive and undervalued, with a PE ratio of 28.91, an EV to EBITDA of 18.57, and a ROCE of 17.66%, making it a compelling investment opportunity despite a year-to-date return of -20.34%.
How has been the historical performance of M K Proteins?
M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability has decreased, with profit after tax falling to 8.40 Cr in March 2025, and cash flow from operating activities turning negative at -16.00 Cr.
How has been the historical performance of M K Proteins?
M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in Mar'25 from 245.57 Cr in Mar'24, but down from 314.86 Cr in Mar'23. Key metrics like operating profit and profit after tax have decreased, while total assets and liabilities rose, indicating a challenging operational environment.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
